// App-Quantinova.ai

: FUSOGENIC LIPOSOMES AS A NOVEL NANOTHERAPY AGAINST METASTATIC CLEAR CELL RENAL CELL CARCINOMA

Researchers

Presenter

  • Jan Rudzinski

Principal Investigators

  • Natasha Govindasamy

  • Konstantin Stoletov

  • Adrian Fairey

  • John Lewis

Medical Centers

  • N/A

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Clear cell renal carcinoma

Biomarkers

  • Cyclin Dependent Kinase Inhibitor 2A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved